Agilent Technologies Stock News

Agilent Technologies, Inc. (NYSE:A ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 11:00 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Rodney Gonsalves - Interim CFO, Principal Accounting Officer, VP & Corporate Controller Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Brandon Couill...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place in Vienna, Austria, from September 6–10, 2025. Agilent will spotlight the European launch of its newly expanded Dako Omnis Family of instruments. The Dako Omnis family, including the Dako Omnis 11...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer. MMR IHC Panel pharmDx (Dako Omnis) is indicated as an aid to identify mismatch repair (MMR) deficient CRC patients e...

Agilent Technologies, Inc.'s Q3 2025 earnings beat expectations, with revenue up 10% YoY and GAAP EPS rising 22%, despite margin contraction across all segments. Management raised full-year 2025 guidance, projecting 6.35% revenue growth and higher non-GAAP EPS, signaling confidence in continued business momentum. The company returned over $150M to shareholders through buybacks and dividends, de...

Agilent Technologies, Inc. (NYSE:A ) Q3 2025 Earnings Conference Call August 27, 2025 4:30 PM ET Company Participants Angelica A. Riemann - Senior VP & President of Agilent CrossLab Group Jian Miao Zhang - Senior VP & President of Applied Markets Group Padraig McDonnell - CEO, President & Director Parmeet Ahuja - Vice President of Investor Relations Rodney Gonsalves - Interim CFO, Principal Acc...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% core(1) compared with the third quarter of 2024. Third-quarter GAAP net income was $336 million, or $1.18 per share. This compares with $282 million, or $0.97 ...

Agilent Technologies raised its annual revenue forecast on Wednesday after beating quarterly estimates, betting on improving demand for its medical tools and equipment used in lab research and drug development.

Though many of the biggest names in the investing world have already reported earnings in this most recent cycle, some lesser-known firms remain yet to report. Besides being a key way for investors to monitor companies' progress in achieving their strategic goals, these reports are often a catalyst for share price shifts.